NorthWest Biotherapeutics Inc (NWBO)

[Steady_T]

That might make sense for a well funded company. Alas, Northwest is not a well funded company.

If they filed with the FDA and the FDA requested an additional trail it would put Northwest in possibly a terminal situation.

Much better to reduce the risk as much as possible by going to the UK where the regulators already have a lot of experience with DCvax-l. The production facilities are located in the UK, and those facilities have already been inspected and certified.

Then there is the production capacity issue. It is quite likely that a US approval would swamp the production facilities.

Other than that, your point is OK.